Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries

被引:18
作者
Yuan, Tom Z. [1 ]
Garg, Pankaj [2 ]
Wang, Linya [1 ]
Willis, Jordan R. [3 ]
Kwan, Eric [1 ]
Hernandez, Ana G. Lujan [1 ]
Tuscano, Emily [1 ]
Sever, Emily N. [1 ]
Keane, Erica [4 ]
Soto, Cinque [5 ]
Mucker, Eric M. [6 ]
Fouch, Mallorie E. [7 ]
Davidson, Edgar [7 ]
Doranz, Benjamin J. [7 ]
Kailasan, Shweta [8 ]
Aman, M. Javad [8 ]
Li, Haoyang [9 ]
Hooper, Jay W. [6 ]
Saphire, Erica Ollmann [9 ,10 ]
Crowe, James E. [5 ,11 ,12 ]
Liu, Qiang [1 ]
Axelrod, Fumiko [1 ]
Sato, Aaron K. [1 ]
机构
[1] Twist Biosci, Twist Biopharma, 681 Gateway Blvd, San Francisco, CA 94080 USA
[2] Alamar Biosci, Fremont, CA USA
[3] Scripps Res, IAVI Neutralizing Antibody Ctr, La Jolla, CA USA
[4] Univ Calif Santa Barbara, Neurosci Res Inst, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA
[5] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN USA
[6] US Army, Med Res Inst Infect Dis, Frederick, MD USA
[7] Integral Mol, Philadelphia, PA USA
[8] Integrated BioTherapeut Inc, Rockville, MD USA
[9] La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, La Jolla, CA USA
[10] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[11] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA
[12] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA
基金
比尔及梅琳达.盖茨基金会;
关键词
SARS-CoV-2; neutralizing antibody; COVID-19; spike glycoprotein; synthetic libraries; HUMAN MONOCLONAL-ANTIBODY; RECEPTOR-BINDING DOMAIN; SARS CORONAVIRUS; IDENTIFICATION; RECOGNITION; ENTRY;
D O I
10.1080/19420862.2021.2002236
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Coronavirus disease 2019 (COVID-19) is an evolving global public health crisis in need of therapeutic options. Passive immunization of monoclonal antibodies (mAbs) represents a promising therapeutic strategy capable of conferring immediate protection from SARS-CoV-2 infection. Herein, we describe the discovery and characterization of neutralizing SARS-CoV-2 IgG and VHH antibodies from four large-scale phage libraries. Each library was constructed synthetically with shuffled complementarity-determining region loops from natural llama and human antibody repertoires. While most candidates targeted the receptor-binding domain of the S1 subunit of SARS-CoV-2 spike protein, we also identified a neutralizing IgG candidate that binds a unique epitope on the N-terminal domain. A select number of antibodies retained binding to SARS-CoV-2 variants Alpha, Beta, Gamma, Kappa and Delta. Overall, our data show that synthetic phage libraries can rapidly yield SARS-CoV-2 S1 antibodies with therapeutically desirable features, including high affinity, unique binding sites, and potent neutralizing activity in vitro, and a capacity to limit disease in vivo.
引用
收藏
页数:17
相关论文
共 61 条
[1]  
[Anonymous], IMMUNO PRECISE ANNOU
[2]   SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface [J].
Bertoglio, Federico ;
Meier, Doris ;
Langreder, Nora ;
Steinke, Stephan ;
Rand, Ulfert ;
Simonelli, Luca ;
Heine, Philip Alexander ;
Ballmann, Rico ;
Schneider, Kai-Thomas ;
Roth, Kristian Daniel Ralph ;
Ruschig, Maximilian ;
Riese, Peggy ;
Eschke, Kathrin ;
Kim, Yeonsu ;
Schaeckermann, Dorina ;
Pedotti, Mattia ;
Kuhn, Philipp ;
Zock-Emmenthal, Susanne ;
Woehrle, Johannes ;
Kilb, Normann ;
Herz, Tobias ;
Becker, Marlies ;
Grasshoff, Martina ;
Wenzel, Esther Veronika ;
Russo, Giulio ;
Kroeger, Andrea ;
Brunotte, Linda ;
Ludwig, Stephan ;
Fuehner, Viola ;
Kraemer, Stefan Daniel ;
Duebel, Stefan ;
Varani, Luca ;
Roth, Gunter ;
Cicin-Sain, Luka ;
Schubert, Maren ;
Hust, Michael .
NATURE COMMUNICATIONS, 2021, 12 (01)
[3]   Anatomy of hot spots in protein interfaces [J].
Bogan, AA ;
Thorn, KS .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 280 (01) :1-9
[4]   Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters [J].
Brocato, Rebecca L. ;
Principe, Lucia M. ;
Kim, Robert K. ;
Zeng, Xiankun ;
Williams, Janice A. ;
Liu, Yanan ;
Li, Rong ;
Smith, Jeffrey M. ;
Golden, Joseph W. ;
Gangemi, Dave ;
Youssef, Sawsan ;
Wang, Zhongde ;
Glanville, Jacob ;
Hooper, Jay W. .
JOURNAL OF VIROLOGY, 2020, 94 (22)
[5]   Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability [J].
Brouwer, Philip J. M. ;
Caniels, Tom G. ;
van der Straten, Karlijn ;
Snitselaar, Jonne L. ;
Aldon, Yoann ;
Bangaru, Sandhya ;
Torres, Jonathan L. ;
Okba, Nisreen M. A. ;
Claireaux, Mathieu ;
Kerster, Gius ;
Bentlage, Arthur E. H. ;
van Haaren, Marlies M. ;
Guerra, Denise ;
Burger, Judith A. ;
Schermer, Edith E. ;
Verheul, Kirsten D. ;
van der Velde, Niels ;
van der Kooi, Alex ;
van Schooten, Jelle ;
van Breemen, Marielle J. ;
Bijl, Tom P. L. ;
Sliepen, Kwinten ;
Aartse, Aafke ;
Derking, Ronald ;
Bontjer, Ilja ;
Kootstra, Neeltje A. ;
Wiersinga, W. Joost ;
Vidarsson, Gestur ;
Haagmans, Bart L. ;
Ward, Andrew B. ;
de Bree, Godelieve J. ;
Sanders, Rogier W. ;
van Gils, Marit J. .
SCIENCE, 2020, 369 (6504) :643-+
[6]   Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite [J].
Cerutti, Gabriele ;
Guo, Yicheng ;
Zhou, Tongqing ;
Gorman, Jason ;
Lee, Myungjin ;
Rapp, Micah ;
Reddem, Eswar R. ;
Yu, Jian ;
Bahna, Fabiana ;
Bimela, Jude ;
Huang, Yaoxing ;
Katsamba, Phinikoula S. ;
Liu, Lihong ;
Nair, Manoj S. ;
Rawi, Reda ;
Olia, Adam S. ;
Wang, Pengfei ;
Zhang, Baoshan ;
Chuang, Gwo-Yu ;
Ho, David D. ;
Sheng, Zizhang ;
Kwong, Peter D. ;
Shapiro, Lawrence .
CELL HOST & MICROBE, 2021, 29 (05) :819-+
[7]   Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies [J].
Chen, Rita E. ;
Zhang, Xianwen ;
Case, James Brett ;
Winkler, Emma S. ;
Liu, Yang ;
VanBlargan, Laura A. ;
Liu, Jianying ;
Errico, John M. ;
Xie, Xuping ;
Suryadevara, Naveenchandra ;
Gilchuk, Pavlo ;
Zost, Seth J. ;
Tahan, Stephen ;
Droit, Lindsay ;
Turner, Jackson S. ;
Kim, Wooseob ;
Schmitz, Aaron J. ;
Thapa, Mahima ;
Wang, David ;
Boon, Adrianus C. M. ;
Presti, Rachel M. ;
O'Halloran, Jane A. ;
Kim, Alfred H. J. ;
Deepak, Parakkal ;
Pinto, Dora ;
Fremont, Daved H. ;
Crowe, James E., Jr. ;
Corti, Davide ;
Virgin, Herbert W. ;
Ellebedy, Ali H. ;
Shi, Pei-Yong ;
Diamond, Michael S. .
NATURE MEDICINE, 2021, 27 (04) :717-726
[8]   A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2 [J].
Chi, Xiangyang ;
Yan, Renhong ;
Zhang, Jun ;
Zhang, Guanying ;
Zhang, Yuanyuan ;
Hao, Meng ;
Zhang, Zhe ;
Fan, Pengfei ;
Dong, Yunzhu ;
Yang, Yilong ;
Chen, Zhengshan ;
Guo, Yingying ;
Zhang, Jinlong ;
Li, Yaning ;
Song, Xiaohong ;
Chen, Yi ;
Xia, Lu ;
Fu, Ling ;
Hou, Lihua ;
Xu, Junjie ;
Yu, Changming ;
Li, Jianmin ;
Zhou, Qiang ;
Chen, Wei .
SCIENCE, 2020, 369 (6504) :650-+
[9]   Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain [J].
Chi, Xiaojing ;
Liu, Xiuying ;
Wang, Conghui ;
Zhang, Xinhui ;
Li, Xiang ;
Hou, Jianhua ;
Ren, Lili ;
Jin, Qi ;
Wang, Jianwei ;
Yang, Wei .
NATURE COMMUNICATIONS, 2020, 11 (01)
[10]   Efficient tumor targeting by single-domain antibody fragments of camels [J].
Cortez-Retamozo, V ;
Lauwereys, M ;
Gh, GH ;
Gobert, M ;
Conrath, K ;
Muyldermans, S ;
De Baetselier, P ;
Revets, H .
INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (03) :456-462